Vita Life Sciences Ltd (ASX: VLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Vita Life Sciences Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$135.41 million
P/E Ratio
13.57
Dividend Yield
5.62%
Shares Outstanding
54.38 million
Earnings per share
0.184
Dividend per share
0.14
Year To Date Return
0.19%
Earnings Yield
7.37%
Franking
47.3684210526
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Vita Life Sciences Ltd (ASX: VLS)
Latest News
No posts found.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 27 Mar 2026 | $0.0950 | 47.37% | Final | 10 Apr 2026 |
| 19 Sep 2025 | $0.0450 | 100.00% | Interim | 03 Oct 2025 |
| 21 Mar 2025 | $0.0650 | 100.00% | Final | 11 Apr 2025 |
| 20 Sep 2024 | $0.0350 | 100.00% | Interim | 04 Oct 2024 |
| 22 Mar 2024 | $0.0600 | 100.00% | Final | 12 Apr 2024 |
| 22 Sep 2023 | $0.0300 | 100.00% | Interim | 06 Oct 2023 |
| 17 Mar 2023 | $0.0325 | 100.00% | Final | 14 Apr 2023 |
| 23 Sep 2022 | $0.0275 | 100.00% | Interim | 07 Oct 2022 |
| 18 Mar 2022 | $0.0300 | 100.00% | Final | 07 Apr 2022 |
| 23 Sep 2021 | $0.0275 | 100.00% | Interim | 08 Oct 2021 |
| 19 Mar 2021 | $0.0275 | 100.00% | Final | 07 Apr 2021 |
| 24 Sep 2020 | $0.0150 | 100.00% | Interim | 09 Oct 2020 |
| 19 Mar 2020 | $0.0225 | 100.00% | Final | 03 Apr 2020 |
| 24 Sep 2019 | $0.0150 | 100.00% | Interim | 08 Oct 2019 |
| 20 Mar 2019 | $0.0225 | 100.00% | Final | 05 Apr 2019 |
| 24 Sep 2018 | $0.0150 | 100.00% | Interim | 08 Oct 2018 |
| 19 Mar 2018 | $0.0225 | 100.00% | Final | 29 Mar 2018 |
| 21 Sep 2017 | $0.0000 | 100.00% | Interim | 05 Oct 2017 |
| 16 Mar 2017 | $0.0225 | 0.00% | Final | 23 Mar 2017 |
| 21 Sep 2016 | $0.0150 | 0.00% | Interim | 30 Sep 2016 |
| 16 Mar 2016 | $0.0225 | 0.00% | Final | 24 Mar 2016 |
| 16 Sep 2014 | $0.0150 | 0.00% | Interim | 25 Sep 2014 |
| 17 Mar 2014 | $0.0200 | 0.00% | Final | 28 Mar 2014 |
| 16 Sep 2013 | $0.0100 | 41.00% | Interim | 27 Sep 2013 |
| 08 Mar 2013 | $0.0050 | 100.00% | Final | 28 Mar 2013 |
| 10 Sep 2012 | $0.0050 | 100.00% | Interim | 16 Oct 2012 |
| 26 Mar 2012 | $0.0050 | 100.00% | Final | 17 Apr 2012 |
| 22 Mar 2011 | $0.0050 | 100.00% | Final | 12 Apr 2011 |
VLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Vita Life Sciences Ltd
Vita Life Sciences Ltd. engages in the formulation, packaging, sale, and distribution of vitamins and supplements. It operates through the following geographical segments: Australia, Singapore, Malaysia, and Others. The Others segment consists of business operations in Thailand, Vietnam, Indonesia, and China. The company was founded in 1947 and is headquartered in Kirrawee, Australia.
VLS Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 16 Apr 2026 | $2.49 | $-0.06 | -2.35% | 2,690 | $2.55 | $2.55 | $2.49 |
| 15 Apr 2026 | $2.55 | $-0.04 | -1.54% | 49,289 | $2.58 | $2.58 | $2.55 |
| 13 Apr 2026 | $2.59 | $0.00 | 0.00% | 4,956 | $2.59 | $2.59 | $2.59 |
| 10 Apr 2026 | $2.59 | $0.01 | 0.39% | 10,433 | $2.60 | $2.60 | $2.59 |
| 09 Apr 2026 | $2.58 | $-0.02 | -0.77% | 3,747 | $2.59 | $2.59 | $2.58 |
| 08 Apr 2026 | $2.60 | $0.03 | 1.17% | 13,138 | $2.60 | $2.60 | $2.58 |
| 07 Apr 2026 | $2.57 | $0.06 | 2.39% | 4,615 | $2.55 | $2.57 | $2.55 |
| 02 Apr 2026 | $2.51 | $-0.01 | -0.40% | 6,918 | $2.52 | $2.52 | $2.51 |
| 01 Apr 2026 | $2.52 | $0.00 | 0.00% | 15,677 | $2.51 | $2.52 | $2.50 |
| 31 Mar 2026 | $2.52 | $0.04 | 1.61% | 330 | $2.52 | $2.53 | $2.52 |
| 30 Mar 2026 | $2.48 | $-0.12 | -4.62% | 11,379 | $2.49 | $2.56 | $2.48 |
| 27 Mar 2026 | $2.60 | $0.03 | 1.17% | 87,383 | $2.48 | $2.60 | $2.48 |
| 26 Mar 2026 | $2.57 | $-0.02 | -0.77% | 289 | $2.57 | $2.59 | $2.57 |
| 25 Mar 2026 | $2.59 | $0.07 | 2.78% | 4,699 | $2.57 | $2.62 | $2.57 |
| 23 Mar 2026 | $2.52 | $-0.02 | -0.79% | 30,508 | $2.53 | $2.54 | $2.52 |
| 20 Mar 2026 | $2.54 | $0.04 | 1.60% | 7,183 | $2.51 | $2.54 | $2.51 |
| 19 Mar 2026 | $2.50 | $0.00 | 0.00% | 23,146 | $2.50 | $2.51 | $2.48 |
| 18 Mar 2026 | $2.50 | $0.00 | 0.00% | 9,470 | $2.50 | $2.52 | $2.50 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 17 Dec 2025 | Henry Townsing | Buy | 130,000 | $318,500 |
Off-market trade.
|
| 07 Oct 2025 | Peter Osborne | Buy | 2,000 | $4,860 |
On-market trade.
|
| 06 May 2025 | Peter Osborne | Buy | 11,090 | $19,185 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Henry George Townsing | Non-Executive DirectorNon-Executive Chairman | Dec 2011 |
Mr Townsing has over 30 years of experience in corporate finance and private equity. He was a Director of the Company, from 1985 to 1992, 2004 to 2009 and was reappointed a director on 22 December 2011.
|
| Mr Andrew O'Keefe | Managing Director | Oct 2016 |
Mr O'Keefe has over 20 years of experience within the Australian pharmaceutical and healthcare industry. During his career Mr O'Keefe has held senior leadership positions in publicly listed companies. Andrew O'Keefe was appointed to the position of Chief Executive Officer - Herbs of Gold Australia in Oct 2014.
|
| Mr Jack Teoh | Non-Executive Director | Sep 2022 |
Mr Teoh is a businessman involved in a range of private companies, with particular experience in finance and technology. He was also a director of Tuas Limited from July 2020 till August 2022, and Total Forms Pty Ltd, a private Australian software business. Mr. Jack Teoh is also on the Board of TPG Telecom as a non-executive director since March 2021.
|
| Mr Peter Osborne | Non-Executive Director | Aug 2023 |
Mr Osborne has experience in business development, sales and marketing, trade development, export and investment facilitation and promotion. He served as Australian Senior Trade Commissioner in Beijing, Shanghai, Hong Kong and Taiwan over 20-years prior to becoming Managing Director Asia for Blackmores Ltd in 2009 - 2020. He is also a director of ATP Science; strategic advisor to Team Global Express, Edison Partners, advisor to Daiken Biomedical (Taiwan) and, external advisor to Bain & Company and Blackstone.
|
| Mr Chin Leng Khoo | Chief Financial OfficerCompany Secretary | Jun 2017 |
-
|
| Chin Leng Khoo | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Chemical Overseas Limited | 8,551,439 | 15.40% |
| Vicky Teoh | 8,435,693 | 15.20% |
| Barings Acceptance Limited | 7,371,832 | 13.30% |
| Anglo Australian Christian & Charitable Fund | 6,276,040 | 11.30% |
| Tie Lim Sung | 4,010,000 | 7.20% |
| HSBC Custody Nominees (Australia) Limited | 3,281,060 | 6.00% |
| South Seas Holdings Pty Limited | 1,345,430 | 2.50% |
| J P Morgan Nominees Australia Pty Limited | 956,902 | 1.80% |
| Andrew Warren O'Keefe | 890,000 | 1.60% |
| Redbrook Nominees Pty Ltd | 816,067 | 1.50% |
| Tan Teik Wei | 811,607 | 1.50% |
| B F A Pty Ltd | 637,591 | 1.20% |
| K S Beh | 524,890 | 0.90% |
| Citicorp Nominees Pty Limited | 329,168 | 0.60% |
| Crx Investments Pty Limited | 300,000 | 0.60% |
| Shaun Rutherford | 291,089 | 0.50% |
| Crx Securities Pty Limited | 270,000 | 0.50% |
| Finclear Services Pty Ltd | 259,299 | 0.50% |
| Kangiara Pty Limited | 252,268 | 0.50% |
| Chin L Khoo | 249,000 | 0.40% |
